These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 4964559)
41. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916 [TBL] [Abstract][Full Text] [Related]
42. [Changing picture of tuberculosis during a decade]. Tveit J Tidsskr Nor Laegeforen; 1971 Apr; 91(12):866-8. PubMed ID: 5554775 [No Abstract] [Full Text] [Related]
43. Primary drug resistance. 3. Oka S; Matsuda T; Kobayashi T Sci Rep Res Inst Tohoku Univ Med; 1972 Nov; 19(3):103-5. PubMed ID: 4632285 [No Abstract] [Full Text] [Related]
44. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
45. The sensitivity to thiacetazone of tubercle bacilli isolated from patients with pulmonary tuberculosis in Sri Lanka. Pinto MR; Arseculeratne SN; Uragoda CG; Weliange LV Tubercle; 1974 Jun; 55(2):129-33. PubMed ID: 4143451 [No Abstract] [Full Text] [Related]
46. [Phythyvazid-resistance of myobacterium tuberculosis and its clinical importance]. Belogurova VP; Dargevich VK Sov Med; 1966 Mar; 29(3):66-72. PubMed ID: 4967965 [No Abstract] [Full Text] [Related]
47. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970]. Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965 [No Abstract] [Full Text] [Related]
48. Drug resistance among previously treated tuberculosis patients, a brief report. Costello HD; Caras GJ; Snider DE Am Rev Respir Dis; 1980 Feb; 121(2):313-6. PubMed ID: 6767427 [TBL] [Abstract][Full Text] [Related]
49. [Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid]. Bialik IB; Klimenko MT Klin Med (Mosk); 1985 Dec; 63(12):42-7. PubMed ID: 3937942 [No Abstract] [Full Text] [Related]
50. [Correlation of lipid fractions, toxicity and virulence of M. tuberculosis isolated from patients treated with antibacterial preparations]. Nemsadze MN Probl Tuberk; 1971; 49(11):66-9. PubMed ID: 5004859 [No Abstract] [Full Text] [Related]
51. [Mode of action of "tuverculostatics". Consequences for the therapy]. Krebs A Z Tuberk Erkr Thoraxorg; 1968; 128(1):208-17. PubMed ID: 4973006 [No Abstract] [Full Text] [Related]
52. [Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients]. Belogurova VP; NavrotskiÄ VV Antibiotiki; 1970 May; 15(5):434-7. PubMed ID: 4988018 [No Abstract] [Full Text] [Related]
53. Evaluation of cycloserine as an antituberculous drug. Gomi J Scand J Respir Dis Suppl; 1970; 71():130-2. PubMed ID: 5317742 [No Abstract] [Full Text] [Related]
57. [The problem of infectiousness of tuberculosis patients during chemotherapy]. Schulthess HK; Zollikofer H Schweiz Med Wochenschr; 1981 Feb; 111(8):251-4. PubMed ID: 6785880 [TBL] [Abstract][Full Text] [Related]
59. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)]. Belogurova VP; Ivanitskaia NN Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204 [No Abstract] [Full Text] [Related]
60. [Internal medicine treatment of pulmonary tuberculosis]. Schaich W Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]